Abstract: A design for a self-expanding intervertebral device is described for use in spinal stabilization. The device is designed to be collapsed into a smaller form for ease of implantation and then re-expand to a larger, final size in order to first distract and then maintain this distraction rigidly once implanted. In all forms of the device, the key design element comprises angled or rounded internal structural members to allow ease of initial deformation. Other key features include no mechanically moving parts, implant is a single piece device, and the device contains a cavity for placement of suitable additional material to augment structural strength or promote bone fusion. The device design is applicable to devices designed for placement between adjacent vertebral endplates or longer (taller) constructs spanning non-adjacent endplates.

Abstract: Compounds of the formula Y3(R4)—X—Y1(R1R2)—Z—Y2(R2)—A—B where the symbols have the meaning defined in the specification, have retinoid, retinoid antagonist or retinoid inverse agonist type biological activity.

Abstract: Compounds of the formula

Abstract: Compounds of the formula Y3(R4)—X—Y1(R1R2)—Z—Y2(R2)—A—B where the symbols have the meaning defined in the specification, have retinoid, retinoid antagonist or retinoid inverse agonist type biological activity.

Abstract: A crystal ball or globe display system (10) including a support base (14) and a display (11) mounted to the support base (14). The globe display system (10) also includes a globe assembly (13) mounted to the support base (14), the globe assembly (13) comprising an transparent enclosure (12) surrounding the display (11). The enclosure (12) defines a space filled with a fluid, wherein the display (11) is contained within the fluid. The globe display system (10) further comprises an audio producing mechanism housed in the support base (14). The audio producing mechanism is driven by a touch sensitive mechanism which is activated upon contact with the globe assembly (13). The crystal ball or globe display system (10) is attained where the display (11) is contained in the fluid-filled globe display system (10) and adapted to activate and de-activate digital sound for entertainment and enjoyment.

Abstract: Retinoid compounds which repress expression of the gene promoted by AP1 protein but which do not significantly activate expression of the genes having RA-responsive elements in their promoter region through RAR&agr; and RAR&Ggr; receptor subtypes, are used, with reduced side effects, for treating diseases and conditions which are responsive to therapy with retinoids.

Abstract: Compounds of the formula where the symbols have the meaning defined in the specification, have retinoid, retinois antagonist or retinoid inverse agonist type biological activity.

Abstract: Compounds of the formula where the symbols have the meaning defined in the specification, have retinoid, retinois antagonist or retinoid inverse agonist type biological activity.

Abstract: Compounds of the formula Y3(R4)—X—Y1(R1R2)—Z—Y2(R2)—A—B where the symbols have the meaning defined in the specification, have retinoid, retinoid antagonist or retinoid inverse agonist type biological activity.

Abstract: Compounds of the formula ##STR1## where the symbols have the meaning defined in the specification, have retinoid, retinois antagonist or retinoid inverse agonist type biological activity.

Abstract: Retinoid compounds which repress expression of the gene promoted by AP1 protein but which do not significantly activate expression of the genes having RA-responsive elements in their promoter region through RAR.alpha. and RAR.GAMMA. receptor subtypes, are used, with reduced side effects, for treating diseases and conditions which are responsive to therapy with retinoids.

Abstract: A garment having an elongated body of sheet material having a length at least equal to the length of a wearer's upper torso, and a width at least twice the width of said torso, the garment body including three arm receiving openings arranged longitudinally thereon, said openings including a center opening approximately on the transverse center at substantially a midpoint of the width of the garment body, and two side openings each to one side of the center opening, said three openings being separated by a distance approximately equal to the width of said torso.

Abstract: A composition of matter comprising crystalline zinc chelated with animal prostate extract provides a convenient source of both fatty acids and zinc for dietary and therapeutic purposes. The pharmaceutical composition is useful for the treatment of diabetes.

Abstract: Compounds of the formulaY.sub.3 (R.sub.4)--X--Y.sub.1 (R.sub.1 R.sub.2)--Z--Y.sub.2 (R.sub.2)--A--Bwhere the symbols have the meaning defined in the specification, have retinoid, retinoid antagonist or retinoid inverse agonist type biological activity.

Abstract: Compounds of the formula ##STR1## wherein R.sub.1 -R.sub.5 X, Y, A, B are as defined in the specification, have retinoid-like biological activity.

Abstract: Compositions and methods are useful for alleviating symptoms of diabetes in mammals. Some of the compositions include a zinc salt and cyclo-Hispro, and optionally contain arachidonic acid. Alternative compositions include a zinc salt, arachidonic acid and L-histidine. The compositions can be administered by oral route according to a daily regimen to result in decreased blood glucose concentrations.

Abstract: Compounds of the formula ##STR1## where the symbols have the meaning described in the application, have retinoid-like or retinoid antagonist-like biological activity.

Abstract: Compounds of the formula ##STR1## have retinoid-like or retinoid antagonist-like biological activity.

Abstract: Compounds of the formula ##STR1## wherein R.sub.1 -R.sub.5 X, Y, A, B are as defined in the specification have retinoid-like biological activity.

Abstract: Compounds of the formula ##STR1## which have retinoid-like biological activity.